Skip to main content
I

INTCO MEDICAL TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 300677 LEI · 549300U6H4L6SSU31U28 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,889 across all filing types
Latest filing 2026-04-23 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 300677

About INTCO MEDICAL TECHNOLOGY CO., LTD.

https://www.intcomedical.com.cn

INTCO Medical Technology Co., Ltd. is a high-tech manufacturer specializing in the research, development, production, and marketing of medical consumables and durable medical equipment. The company's primary product portfolio includes a wide range of disposable medical gloves, such as nitrile, vinyl, and latex varieties, which serve as critical protective gear in healthcare and industrial settings. Beyond consumables, the firm produces durable medical equipment including manual and electric wheelchairs, hospital beds, and patient mobility aids. It also offers physical therapy products like cold and hot packs and various medical electrodes. With a focus on large-scale production and advanced manufacturing technology, the company serves a global clientele across healthcare, laboratory, and food service sectors. Its operations emphasize quality control and compliance with international standards to ensure product safety and reliability.

Recent filings

Filing Released Lang Actions
关于2025年度利润分配预案的公告
Notice of Dividend Amount Classification · 1% confidence The document is an announcement by the company’s board of the 2025 profit distribution (dividend) proposal, detailing cash dividend per 10 shares, board and audit committee resolutions, related calculations, and regulatory references. It is not the full annual report or audit report itself, nor a simple publication notice, but a substantive dividend distribution announcement to shareholders. Thus, it matches the “Notice of Dividend Amount” category.
2026-04-23 Chinese
关于召开公司2025年度股东会的通知
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a notice to convene the company’s 2025 Annual Shareholders’ Meeting, detailing meeting date/time, agenda items, voting procedures, proxy forms and attachments. It is not the meeting materials themselves (AGM information) nor a report publication. Rather, it is a proxy solicitation/information statement provided to shareholders to inform and request votes, matching the Proxy Solicitation & Information Statement category.
2026-04-23 Chinese
董事、高级管理人员薪酬管理制度
Governance Information Classification · 1% confidence The text is an internal corporate policy titled “Board and Senior Management Compensation Management System” for 英科医疗科技股份有限公司, detailing principles, processes, and oversight of director and senior management remuneration. It is not a financial report, proxy statement, or transaction announcement but a governance rulebook on compensation. This aligns with Governance Information (CGR).
2026-04-23 Chinese
关于部分会计政策变更的公告
Regulatory Filings Classification · 1% confidence The document is an official announcement (公告) by a listed company disclosing changes in accounting policies mandated by the Ministry of Finance. It is not a full financial report (10-K or IR), not an audit opinion (AR), nor a notice of dividends, voting, M&A, or other transactional or operational items. Instead, it is a regulatory disclosure required under exchange listing rules. This fits the fallback “Regulatory Filings” category (RNS).
2026-04-23 Chinese
关于开展外汇衍生品交易业务的可行性分析报告
Regulatory Filings Classification · 1% confidence The document is a detailed feasibility analysis and risk management plan for engaging in foreign exchange derivatives trading. It is not an AGM presentation (AGM-R), an Annual Report (10-K), an earnings release (ER), or any of the other narrowly defined filings (e.g., share issues, M&A, dividends, etc.). It appears to be a compliance announcement under listing rules regarding proposed derivative activities and internal control measures rather than the actual derivative contracts or a capital raising. This falls into the general category of regulatory or compliance filings that do not fit the other specific categories. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-04-23 Chinese
第四届董事会第十四次（定期）会议决议公告
Regulatory Filings
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.